Slo-Bid
Acute Bronchitis, Bronchial Spasm, Asthma + 8 more
Treatment
7 FDA approvals
20 Active Studies for Slo-Bid
Treatment for
Acute Bronchitis
What is Slo-Bid
Theophylline
The Generic name of this drug
Treatment Summary
Theophylline is a drug derived from tea leaves that has multiple effects on the body. It is a diuretic, muscle relaxant, and stimulant for the heart and central nervous system. It works by blocking certain enzymes and activating a type of protein that can help with breathing. Theophylline is sold under the names Uniphyl and Theochron and is mainly used to treat asthma, bronchospasm, and COPD.
Elixophyllin
is the brand name
Slo-Bid Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Elixophyllin
Theophylline
1979
114
Approved as Treatment by the FDA
Theophylline, commonly known as Elixophyllin, is approved by the FDA for 7 uses like Chronic Bronchitis and Lung Disorder .
Chronic Bronchitis
Lung Disorder
Asthma
Asthma
Bronchitis, Chronic
Bronchoconstriction
Lung Diseases
Effectiveness
How Slo-Bid Affects Patients
Theophylline, a substance related to caffeine and theobromine, is used to treat asthma and breathing difficulties. It has two effects in people with asthma: it helps the airways open up (bronchodilation) and also prevents the airways from constricting in response to triggers (non-bronchodilator prophylactic effects).
How Slo-Bid works in the body
Theophylline reduces inflammation and relaxes the muscles in the airways, making breathing easier. It works by blocking an enzyme that breaks down a molecule that helps control muscle contraction. It also blocks a receptor that allows a molecule to cause the airways to constrict. In addition, it activates a type of enzyme to prevent inflammation-causing molecules from being activated.
When to interrupt dosage
The proposed dosage of Slo-Bid is contingent upon the diagnosed condition, such as Bronchodilation, Bronchoconstriction and Chronic Obstructive Pulmonary Disease (COPD). The amount of dosage shall be determined according to the administration technique detailed in the table below.
Condition
Dosage
Administration
Chronic Obstructive Pulmonary Disease
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution - Intravenous, Injection, solution, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Capsule, extended release, Capsule, extended release - Oral, Tablet - Oral, Syrup, Syrup - Oral, Elixir - Oral, Elixir, Capsule, Kit, Injection, Injection - Intravenous, Solution - Intravenous, Capsule - Oral
Asthma
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution - Intravenous, Injection, solution, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Capsule, extended release, Capsule, extended release - Oral, Tablet - Oral, Syrup, Syrup - Oral, Elixir - Oral, Elixir, Capsule, Kit, Injection, Injection - Intravenous, Solution - Intravenous, Capsule - Oral
Bronchitis, Chronic
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution - Intravenous, Injection, solution, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Capsule, extended release, Capsule, extended release - Oral, Tablet - Oral, Syrup, Syrup - Oral, Elixir - Oral, Elixir, Capsule, Kit, Injection, Injection - Intravenous, Solution - Intravenous, Capsule - Oral
Airway secretion clearance therapy
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution - Intravenous, Injection, solution, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Capsule, extended release, Capsule, extended release - Oral, Tablet - Oral, Syrup, Syrup - Oral, Elixir - Oral, Elixir, Capsule, Kit, Injection, Injection - Intravenous, Solution - Intravenous, Capsule - Oral
Acute Bronchitis
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution - Intravenous, Injection, solution, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Capsule, extended release, Capsule, extended release - Oral, Tablet - Oral, Syrup, Syrup - Oral, Elixir - Oral, Elixir, Capsule, Kit, Injection, Injection - Intravenous, Solution - Intravenous, Capsule - Oral
Bronchial Spasm
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution - Intravenous, Injection, solution, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Capsule, extended release, Capsule, extended release - Oral, Tablet - Oral, Syrup, Syrup - Oral, Elixir - Oral, Elixir, Capsule, Kit, Injection, Injection - Intravenous, Solution - Intravenous, Capsule - Oral
Emphysema
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution - Intravenous, Injection, solution, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Capsule, extended release, Capsule, extended release - Oral, Tablet - Oral, Syrup, Syrup - Oral, Elixir - Oral, Elixir, Capsule, Kit, Injection, Injection - Intravenous, Solution - Intravenous, Capsule - Oral
Bronchoconstriction
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution - Intravenous, Injection, solution, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Capsule, extended release, Capsule, extended release - Oral, Tablet - Oral, Syrup, Syrup - Oral, Elixir - Oral, Elixir, Capsule, Kit, Injection, Injection - Intravenous, Solution - Intravenous, Capsule - Oral
Lung Diseases
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution - Intravenous, Injection, solution, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Capsule, extended release, Capsule, extended release - Oral, Tablet - Oral, Syrup, Syrup - Oral, Elixir - Oral, Elixir, Capsule, Kit, Injection, Injection - Intravenous, Solution - Intravenous, Capsule - Oral
Bronchodilation
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution - Intravenous, Injection, solution, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Capsule, extended release, Capsule, extended release - Oral, Tablet - Oral, Syrup, Syrup - Oral, Elixir - Oral, Elixir, Capsule, Kit, Injection, Injection - Intravenous, Solution - Intravenous, Capsule - Oral
Bronchitis, Chronic
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution - Intravenous, Injection, solution, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Capsule, extended release, Capsule, extended release - Oral, Tablet - Oral, Syrup, Syrup - Oral, Elixir - Oral, Elixir, Capsule, Kit, Injection, Injection - Intravenous, Solution - Intravenous, Capsule - Oral
Warnings
There are 20 known major drug interactions with Slo-Bid.
Common Slo-Bid Drug Interactions
Drug Name
Risk Level
Description
Acenocoumarol
Major
The metabolism of Acenocoumarol can be decreased when combined with Theophylline.
Aminophylline
Major
The metabolism of Aminophylline can be decreased when combined with Theophylline.
Axitinib
Major
The metabolism of Axitinib can be decreased when combined with Theophylline.
Bendamustine
Major
The metabolism of Bendamustine can be decreased when combined with Theophylline.
Brigatinib
Major
The metabolism of Brigatinib can be decreased when combined with Theophylline.
Slo-Bid Toxicity & Overdose Risk
Overdosing on this drug can cause seizures, abnormal heart rhythms, and gastrointestinal problems.
Slo-Bid Novel Uses: Which Conditions Have a Clinical Trial Featuring Slo-Bid?
280 active clinical trials are being conducted to assess the effectiveness of Slo-Bid in providing Bronchodilation, alleviating Chronic Bronchitis and mitigating Asthma symptoms.
Condition
Clinical Trials
Trial Phases
Chronic Obstructive Pulmonary Disease
66 Actively Recruiting
Phase 3, Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 4
Asthma
77 Actively Recruiting
Phase 1, Phase 4, Early Phase 1, Not Applicable, Phase 2, Phase 3
Airway secretion clearance therapy
0 Actively Recruiting
Bronchoconstriction
0 Actively Recruiting
Bronchodilation
0 Actively Recruiting
Emphysema
4 Actively Recruiting
Phase 2, Not Applicable
Bronchitis, Chronic
0 Actively Recruiting
Acute Bronchitis
1 Actively Recruiting
Not Applicable
Bronchitis, Chronic
0 Actively Recruiting
Lung Diseases
3 Actively Recruiting
Phase 1, Phase 2, Not Applicable
Bronchial Spasm
0 Actively Recruiting
Patient Q&A Section about slo-bid
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What are the side effects of Bid?
"The Bid 125 MG Tablet may cause side effects such as diarrhoea, stomach pain, headache, weakness, nausea, and vomiting. If these symptoms persist, please contact your doctor. Do not take this medicine if you are previously allergic to it. The Bid 125 MG Tablet is not recommended for use in children below 12 years of age."
Answered by AI
What drug is SLO?
"Slo-Phyllin is a bronchodilator that is used to relieve and/or prevent symptoms of asthma and reversible bronchospasm that is associated with chronic bronchitis and emphysema. The brand name Slo-Phyllin has been discontinued, but there may be generic versions of the drug that are available."
Answered by AI
What does theophylline do?
"This makes it easier to breathe.
Theophylline is a bronchodilator that is used to treat the symptoms of asthma, bronchitis, and emphysema. Bronchodilators are medicines that relax the muscles in the bronchial tubes (air passages) of the lungs. This makes it easier to breathe."
Answered by AI